April 15, 2020

U.S. Drug Supply Critically Affected by COVID-19, Foreign Sourcing

Pharmacists should brace themselves for continued shortages of critical drugs as the COVID-19 pandemic continues. Find out what issues complicate the drug supply in the United States and which products are most likely to experience critical shortages.


Labels for Pediatric Use Are Updated
on Some Commonly Used Drugs

New research has led the FDA to mandate improved labeling for some key drugs used for pediatric patients. Here is information on what the new labels state for doxycycline, clindamycin, and caffeine citrate.

C Difficile Infections Show Substantial Decline

In the midst of the novel coronavirus outbreak, it might be comforting for pharmacists and other healthcare professionals to realize that, working together, they can vanquish serious life-threatening infections. That is exactly what has happened with Clostridioides difficile infection in hospitals. Find out how much those infections declined over a 7-year period and why.


Make Sure Ranitidine Products Are Not Returned to Pharmacy

The FDA announced it is requesting that manufacturers withdraw all prescription and OTC ranitidine drugs from the market immediately and advising consumers to stop taking any OTC ranitidine they currently have and dispose of the drugs properly. However, because of the COVID-19 pandemic, drugs should not be returned to a take-back location, the FDA cautions. Here is more information.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -